Iroko Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Iroko Pharmaceuticals

Access the complete profile.

Iroko Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3945 Freedom Circle Suite 560 Santa Clara, CA 95054

Note: Revenues for privately held companies are statistical evaluations.


Iroko Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Iroko Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Iroko Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Iroko Pharmaceuticals Annual Revenue and Growth Rate

Iroko Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Iroko Pharmaceuticals's revenues are gauged from an analysis of company filings.

Iroko Pharmaceuticals's Income Statement (based on Industry Averages)

Iroko Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Iroko Pharmaceuticals is developing and marketing. Iroko Pharmaceuticals doesn't have any recent trademark applications, indicating Iroko Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
Z Pharmaceutical preparations for the treatment of pain and pain associated with inflammation	09/04/2013
IROKO PHARMACEUTICALS, LLC development of pharmaceutical preparations	01/25/2011

See all trademarks and details in the Full Report.

Market Share of Iroko Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Iroko Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Iroko Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ALPHA TEKNOVA	Hollister, CA	100
FOSUN PHARMA USA	Santa Clara, CA	28
VIVUS	Campbell, CA	17
NOODLE & BOO	Los Gatos, CA	3
HANDA PHARMACEUTICALS	Saratoga, CA	3
RASILIENT SYSTEMS	Santa Clara, CA	2

Other Companies at 3945 Freedom Circle, Santa Clara CA

Company	Headquarters	Revenue ($ MM)
EDELMAN FINANCIAL ENGINES	Santa Clara, CA	100
ALIBABA.COM U.S.	Santa Clara, CA	14
JFROG	Santa Clara, CA	10
IDEMITSU RENEWABLES AMERICAS DEVELOPMENT	Santa Clara, CA	7
TALROO	Santa Clara, CA	2

Future Competition: Iroko Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Iroko Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)